Catherine A. Sazdanoff's most recent trade in InMed Pharmaceuticals Inc was a trade of 7,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 29, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc | Catherine A. Sazdanoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2021 | 7,000 | 29,091 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Catherine A. Sazdanoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 11,000 | 11,000 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Catherine A. Sazdanoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 7,000 | 7,000 | - | - | Employee Stock Option (Right to Buy) |